What was once known as non-alcoholic fatty liver disease now has a new title: metabolic dysfunction-associated steatotic liver disease, or MASLD.
MASLD can get worse and turn into metabolic dysfunction-associated steatohepatitis, or MASH. In this video, learn what MASH is, according to Alyson Fox, MD, MSCE, Transplant Hepatologist at Columbia University’s Irving Medical Center.
Alyson Fox, MD, is the Medical Director of the Adult Liver Transplant Program at Columbia University’s Irving Medical Center. She specializes in a variety of liver conditions, including viral hepatitis, alcohol-related liver disease, metabolic dysfunction-associated steatotic liver disease, and liver cancer.
References
American Academy of Family Physicians. (2024). Nonalcoholic fatty liver disease (metabolic dysfunction-associated steatotic liver disease).
American Liver Foundation. (2025). Metabolic dysfunction-associated steatotic liver disease (MASLD).
Likhitsup, A. (2024). Metabolic dysfunction-associated steatotic liver disease (MASLD). American College of Gastroenterology.
Miao L., et al. (2024). Current status and future trends of the global burden of MASLD. Trends in Endocrinology & Metabolism.
National Institute of Diabetes and Digestive and Kidney Diseases. (2021). Definition & facts of NAFLD & NASH.
Sharma, B., et al. (2023). Nonalcoholic steatohepatitis. StatPearls.
Why trust our experts?


